SCHEMBL292539

SCHEMBL292539

CC(C)(C)OC(=O)N1CC(=O)N(c2ccccc2)CC1(C)C

nearest known ligand 0.45

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
NR1H2 P55055 1/20 0.45
NR1H3 Q13133 1/20 0.45
USP30 Q70CQ3 1/20 0.43
GPR119 Q8TDV5 1/20 0.41
REN P00797 2/20 0.38
RORC P51449 5/20 0.38
ALDH1A1 P00352 1/20 0.38
GAA P10253 1/20 0.38
MAPT P10636 1/20 0.38
G6PD P11413 1/20 0.38
SMN1; SMN2 Q16637 1/20 0.38
BUB1 O43683 1/20 0.36
MAPK1 P28482 1/20 0.36
BCHE P06276 1/20 0.35
MT-CO2 P00403 1/20 0.35
ALOX5 P09917 1/20 0.35
NPC1 O15118 1/20 0.35
PPARG P37231 1/20 0.35
PPARD Q03181 1/20 0.35
PPARA Q07869 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL292245 0.84 NR1H2 (0.39) NR1H2NR1H3USP30RENRORC
SCHEMBL292987 0.84 MAPT (0.41) NR1H2NR1H3RENMAPTBCHE
SCHEMBL291695 0.83 REN (0.45) REN
SCHEMBL24792960 0.82 NR1H2 (0.36) NR1H2NR1H3USP30GPR119REN
SCHEMBL29709703 0.82 NR1H2 (0.36) NR1H2NR1H3USP30GPR119REN
SCHEMBL293228 0.82 REN (0.44) RENALDH1A1MAPTSMN1; SMN2BCHE
SCHEMBL292549 0.81 REN (0.41) NR1H2NR1H3USP30GPR119REN
SCHEMBL22054795 0.81 TMEM97 (0.45) RENALDH1A1GAAMAPTG6PD
SCHEMBL27776020 0.80 HDAC1 (0.36) NR1H2NR1H3RENBCHE
SCHEMBL292759 0.80 REN (0.38) NR1H2NR1H3USP30GPR119REN

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-101511799-B Cyclic amine compound DAIICHI SANKYO CO LTD 2012-05-30 CN disclosed
US-8158790-B2 Cyclic amine compound DAIICHI SANKYO COMPANY, LIMITED (JP) 2012-04-17 US disclosed
EP-2036896-B1 CYCLIC AMINE COMPOUND DAIICHI SANKYO CO LTD (JP) 2012-03-14 EP disclosed
US-20090286807-A1 CYCLIC AMINE COMPOUND DAIICHI SANKYO COMPANY, LIMITED (JP) 2009-11-19 US disclosed
CN-101511799-A Cyclic amine compound DAIICHI SANKYO CO LTD (JP) 2009-08-19 CN disclosed
EP-2036896-A1 CYCLIC AMINE COMPOUND Daiichi Sankyo Company, Limited (JP) 2009-03-18 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20090286807-A1 CYCLIC AMINE COMPOUND HRH3, HRH4, H1-0 NR1H2 45/4885NR1H3 41/4885USP30 3407/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.